BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18440943)

  • 1. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters.
    Horger M; Pereira P; Claussen CD; Kanz L; Vonthein R; Denecke B; Driessen C
    Br J Radiol; 2008 May; 81(965):386-96. PubMed ID: 18440943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
    Horger M; Kanz L; Denecke B; Vonthein R; Pereira P; Claussen CD; Driessen C
    Cancer; 2007 Apr; 109(8):1617-26. PubMed ID: 17330855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
    Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
    Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma.
    Nishida Y; Matsue Y; Suehara Y; Fukumoto K; Fujisawa M; Takeuchi M; Ouchi E; Matsue K
    Blood Cancer J; 2015 Jul; 5(7):e329. PubMed ID: 26230953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
    Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
    Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
    AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma.
    Matsue K; Kobayashi H; Matsue Y; Abe Y; Narita K; Kitadate A; Takeuchi M
    Blood Adv; 2018 May; 2(9):1032-1039. PubMed ID: 29739774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.
    Horger M; Claussen CD; Bross-Bach U; Vonthein R; Trabold T; Heuschmid M; Pfannenberg C
    Eur J Radiol; 2005 May; 54(2):289-97. PubMed ID: 15837412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Becker C; Schoenberg SO; Lang N; Bartl R; Reiser MF
    AJR Am J Roentgenol; 2008 Apr; 190(4):1097-104. PubMed ID: 18356461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma.
    Razek AA; Ezzat A; Azmy E; Tharwat N
    Radiol Med; 2013 Aug; 118(5):799-805. PubMed ID: 22986700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
    Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned.
    Bier G; Mustafa DF; Kloth C; Weisel K; Ditt H; Nikolaou K; Horger M
    AJR Am J Roentgenol; 2016 Jan; 206(1):57-63. PubMed ID: 26700335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.
    Kröpil P; Fenk R; Fritz LB; Blondin D; Kobbe G; Mödder U; Cohnen M
    Eur Radiol; 2008 Jan; 18(1):51-8. PubMed ID: 17924119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).
    Zacchino M; Bonaffini PA; Corso A; Minetti V; Nasatti A; Tinelli C; Dore R; Calliada F; Sironi S
    Eur Radiol; 2015 Nov; 25(11):3382-9. PubMed ID: 25987427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography.
    Mahnken AH; Wildberger JE; Gehbauer G; Schmitz-Rode T; Blaum M; Fabry U; Günther RW
    AJR Am J Roentgenol; 2002 Jun; 178(6):1429-36. PubMed ID: 12034612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    J Comput Assist Tomogr; 2007; 31(3):342-7. PubMed ID: 17538276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.